Drugs / Moxonidin
last change Dec 2008 re-read 2 minutes ago

Moxonidin

Developed for
coronary microvascular disorder · essential hypertension
Investigated by
Danish Cardiovascular Research Academy · Danish Heart Foundation · Novartis · University of Aarhus

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT00424801 Jan 2007 → Dec 2008 coronary microvascular disorder, essential hypertension University of Aarhus Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Moxonidin ClinicalTrials.gov intervention name — accepted as the source's own label NCT00424801